The end of 2007 marked an important step in the history of the HIV/AIDS epidemic. Nearly three million people are now receiving antiretroviral therapy in low- and middle-income countries, according to a new World Health Organization, UNAIDS and UNICEF report released on June 2.
Titled Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector , it also points to other gains. These include improved access to interventions aimed at preventing mother-to-child transmission of HIV (PMTCT), expanded testing and counselling, and greater country commitment to male circumcision in heavily affected regions of sub-Saharan Africa.
"This represents a remarkable achievement for public health," says WHO Director General Margaret Chan, adding that "this proves that, with commitment and determination, all obstacles can be overcome. People living in resource-constrained settings can indeed be brought back to economically and socially productive lives by these drugs."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze